Planta Med 2006; 72(14): 1273-1278
DOI: 10.1055/s-2006-947241
Original Paper
Pharmacology
© Georg Thieme Verlag KG Stuttgart · New York

Inter-Species Variability of Haplamine Metabolism and Identification of its Phase I Metabolites from Liver Microsomes

Sompheary Ea1 , Sok-Siya Bun2 , Claude Aubert1 , Valentina Akhmedjanova4 , Evelyne Ollivier2 , Chhan Siv3 , Hot Bun1
  • 1Laboratory of Pharmacokinetics and Toxicokinetics, EA 3286, Faculty of Pharmacy, Marseille, France
  • 2Laboratory of Pharmacognosy, Faculty of Pharmacy, Marseille, France
  • 3Laboratory of Organo-Phosphorus UMR CNRS 6180, University of Paul Cézanne, Marseille, France
  • 4Uzbek Academy of Sciences, Yunusov Institute of the Chemistry of Plant Substances, Tashkent, Uzbekistan
Further Information

Publication History

Received: April 28, 2006

Accepted: July 25, 2006

Publication Date:
18 September 2006 (online)

Abstract

Haplamine, a pyranoquinoline alkaloid, was isolated from the genus Haplophyllum. The inter-species variability of haplamine metabolism was determined by reversed phase high performance liquid chromatography (HPLC) with UV detection. Microsomes from the liver of rats, mice, rabbits, guinea-pigs and humans were incubated with haplamine. After incubation, samples were extracted with a mixture of ethyl acetate and isopropyl alcohol (90 : 10; v/v). Haplamine and its metabolites were separated by HPLC using Nucleosil C18 Nautilus (5 µm) connected with a precolumn of the same type. The HPLC mobile phase consisted of water (A) and a mixture of methanol and acetonitrile (85 : 15; v/v) (B) used in a gradient mode (17 to 27 % B for 10 min, 27 to 90 % B for 37 min, 90 to 17 % B for 3 min, and finally 17 % B for 3 min) at 1 mL/min. Quantitative and qualitative results showed significant inter-species differences in haplamine metabolism. Qualitative similarities were found between guinea-pigs, rabbits, and humans. The metabolites were isolated by HPLC and identified by GC/MS after silylation. The phase I metabolites identified in human liver microsomes were trans/cis-3,4-dihydroxy-9-O-desmethylhaplamine, trans/cis-3,4-dihydroxyhaplamine and 9-O-desmethylhaplamine.

References

  • 1 Akhmedjanova V I, Bessonova I A, Yunusov S Y u. Alkaloids of Haplophyllum perforatum .  Khim Prirod Soed. 1976;  3 320-8
  • 2 Razakova D M, Bessonova I A, Yunusov S Y u. Components of Haplophyllum acutifolium .  Khim Prirod Soed. 1986;  3 384-5
  • 3 Akhmedzhanova V I, Bessonova I A, Yunusov S Y u. Haplamine, new alkaloid from Haplophyllum perforatum .  Khim Prirod Soed. 1974;  10 109-10
  • 4 Abdullaeva kh A, Bessonova I A, Yunusov S Y u. Alkaloid from Haplophyllum perforatum .  Khim Prirod Soed. 1978;  2 219-23
  • 5 Razakova D M, Bessonova I A, Yunusov S Y u. Alkaloids of Haplophyllum perforatum .  Khim Prirod Soed. 1985;  2 273-4
  • 6 Akhmedkhodzhaeva kh S, Kurmukov A G. Pharmacology of haplamine.  Dokl Akad Nauk UzSSR. 1975;  8 36
  • 7 Jansen O, Akhmedjanova V, Angenot L, Balansard G, Chariot A, Ollivier E. et al . Screening of 14 alkaloids isolated from Haplophyllum A. Juss for their cytotoxic properties.  J Ethnopharmacol. 2006;  105 241-5
  • 8 Cantrell C L, Schrader K K, Mamonov L K, Sitpaeva G T, Kustova T S, Dumbar C. et al . Isolation and identification of antifungal and antialgal alkaloids from Haplophyllum sieversii .  J Agric Food Chem. 2005;  53 7741-8
  • 9 Van der H oeven, Coon M J. Preparation and properties of partially purified cytochrome P450 and reduced nicotinamide adenine dinucleotide phosphate cytochrome P450 reductase from rabbit liver microsomes.  J Biol Chem. 1974;  249 6302-10
  • 10 Bun S S, Ciccolini J, Bun H, Aubert C, Catalin J. Drug interaction of paclitaxel metabolism in human liver microsomes.  J Chemother. 2003;  15 266-74
  • 11 Bradford M M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.  Anal Biochem. 1976;  72 248-54
  • 12 Rontani J F, Christodoulou S, Koblizek M. GC/MS structural characterization of fatty acids from marine aerobic anoxygenic phototrophic bacteria.  Lipids. 2005;  40 97-108
  • 13 Aziz M, Rouessac F. Synthèses d’intermédiaires présentant le motif structural du trimethyl-1,3,3 oxa-7-bicyclo[2.2.1]heptane.  Bull Soc Chim Fr. 1988;  3 555-60
  • 14 Marlene F S, Jiang Z h, Joy C Y, David A T, Charles G P, Gino AC and a l. Cellular characterization of leukotoxin diol-induced mitochondrial dysfunction.  Arch Biochem Biophys. 2001;  391 32-7
  • 15 Felter S P, Vassallo J D, Carlton B D, Daston G P. A safety assessment of coumarin taking into account species-specificity of toxicokinetics.  Food Chem Toxicol. 2006;  44 462-75
  • 16 Slim R, Hammock B D, Toborek M, Robertson L W, Nexman J W, Morisseau C HP. et al . The role of methyl-linoleic acid epoxide and diol metabolites in the amplified toxicity of linoleic acid and polychlorinated biphenyls to vascular endothelial cells.  Toxicol Appl Pharmacol. 2001;  171 184-93
  • 17 Fontaine S M, Hoyer P B, Halpert J R, Sipes I G. Role of induction of specific hepatic cytochrome P450 isoforms in epoxidation of 4-vinylcyclohexene.  Drug Metab Dispos. 2001;  29 1236-42
  • 18 Yamamoto Y, Yamazaki H, Ikeda T, Watanabe T, Iwabuchi H, Nakajima M. et al . Formation of a novel quinone epoxide metabolite of troglitazone with cytotoxic to HepG2 cells.  Drug Metab Dispos. 2002;  30 155-60

Dr. Claude Aubert

Laboratory of Pharmacokinetics and Toxicokinetics

Faculty of Pharmacy

27 Bd Jean Moulin

13385 Marseille cedex 5

France

Phone: +33-4-91-83-55-09

Fax: +33-4-91-83-56-67

Email: claude.aubert@pharmacie.univ-mrs.fr

    >